These were a frameshift variant on ALPK1, a gene with downregulated expression in lung and colorectal tumors [50], and a frameshift variant on ST18, a gene with tumor-suppressing activity in breast tumors [51]. This evidence concerns the gene ST18 and breast neoplasm.